NBOMe Drugs: The Fake Acid Sold on Blotter Paper and Why It Has Caused Deaths

Most of the patients I have spoken with who used NBOMe did not know that is what they had taken. They thought they had LSD. The tell I have heard most often is this: the trip felt wrong from the start, more aggressive in the body, tighter in the chest, not the expansive perceptual shift people expect from classical psychedelics. By the time the seizure or the cardiac event happens, there is very little time to act.

What Is an NBOMe Drug?

NBOMe is shorthand for N-methoxybenzyl, a chemical modification added to the 2C family of phenethylamine psychedelics, most of which were first synthesised by the chemist Alexander Shulgin. The modification dramatically increased potency and shifted the pharmacology in ways that make these compounds substantially more dangerous than their precursors.

The three most commonly encountered variants are 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe. The “25I” prefix tells you the parent compound: 25I means iodine is present at the 4-position of the phenethylamine ring. That matters clinically because iodine-containing compounds tend to have longer half-lives and more pronounced cardiovascular effects than the chlorine or bromine variants, though all three are capable of causing death.

These are New Psychoactive Substances, a regulatory category used internationally to describe synthetic drugs engineered to produce effects similar to controlled substances while initially evading legal control. NBOMes are now controlled in most countries, but they remain widely available on darknet markets.

What Do NBOMe Drugs Look Like?

This is where the real danger starts. NBOMes on blotter paper are visually indistinguishable from LSD. Same small squares, same printed artwork, same tab format. A user holding both in their hands cannot tell the difference by sight, smell, or taste.

NBOMes are also sold as clear liquid, white powder, and occasionally pressed pills. The powder form is particularly hazardous because small weighing errors can push a dose from recreational to lethal. A single microgram is active. Most analytical scales used by recreational users are not sensitive enough to measure that accurately.

Street Names for NBOMe Drugs

On the street and online, NBOMes go by a long list of names. The most common are N-Bomb, 25I, 25C, 25B, Bom-25, Wizard, Solaris, Pandora, Divination, and Smiley Paper. The name “Smiles” is also used in some regions.

The problem with all of these names is that they are rarely what the seller says on the label. In practice, most people who end up in emergency departments after NBOMe exposure were told they were buying LSD, MDMA, or mescaline.

How Are NBOMes Taken and Why That Matters Clinically

NBOMes are not orally active in the traditional sense. Swallowing a tab does not reliably produce effects because the compounds are poorly absorbed through the gastrointestinal tract. They require sublingual or buccal administration, meaning held under the tongue or against the cheek, or insufflation through the nose.

This creates a specific behavioural pattern worth knowing. When someone holds a tab under their tongue for 20 to 30 minutes and still feels nothing, they often take more. That second dose hits alongside the delayed first dose and the combined effect can be overwhelming and dangerous. The delayed onset is a significant contributing factor in overdose deaths.

Onset typically begins 20 to 45 minutes after sublingual administration. Full effects peak around 2 to 4 hours in. The total duration runs 6 to 10 hours, sometimes longer.

NBOMe Effects: What Actually Happens in the Brain

NBOMes act primarily as potent full agonists at the 5-HT2A serotonin receptor. This is the same receptor that LSD activates, which is why the visual and perceptual effects overlap. But LSD is a partial agonist at 5-HT2A, meaning it activates the receptor partially and has a ceiling effect. NBOMes are full agonists. They push the receptor to maximum activation, and they also bind with high affinity to 5-HT2B receptors, which are found in the heart.

5-HT2B receptor activation in cardiac tissue causes valvular changes with chronic use and, in acute high doses, contributes to arrhythmia. That is one reason NBOMe overdoses can kill people who have no prior cardiac history.

At moderate doses, the reported effects include intense visual and auditory hallucinations, euphoria, heightened sensory awareness, enhanced appreciation of music, and altered time perception. These are the effects people are usually seeking.

At higher doses or in sensitive individuals, the picture changes rapidly: severe agitation, paranoia, uncontrollable body movements, elevated body temperature (hyperthermia), rapid heart rate (tachycardia), high blood pressure, and seizures.

Why NBOMe Drugs Are So Much More Dangerous Than LSD

LSD is not safe, but it has several pharmacological features that make it less lethal than NBOMes. The therapeutic index, which is the ratio between the effective dose and the lethal dose, is enormous for LSD. No confirmed human fatality from LSD alone has ever been documented in the scientific literature.

NBOMes have a narrow therapeutic index. The doses that produce hallucinations and the doses that produce seizures and cardiac events overlap substantially. In practice this means there is no reliably safe recreational dose.

Here is what makes the situation worse. Street tabs are not manufactured under controlled conditions. The distribution of active compound across a single blotter sheet is uneven. One corner of a tab can contain three times the dose of the opposite corner. This batch-to-batch and within-tab variability means that two people taking “the same” tab can have completely different clinical presentations.

NBOMe Overdose: What Happens in the Body

The mechanism of death in NBOMe overdose involves several overlapping pathways. Hyperthermia is the most common cause. The 5-HT2A activation drives sustained muscle activity, which generates heat. The person cannot regulate their temperature. Core body temperature can reach 40 to 41 degrees Celsius or higher. At those temperatures, proteins denature, rhabdomyolysis (muscle breakdown) begins, and kidney failure follows.

Simultaneously, the cardiovascular effects drive blood pressure and heart rate into dangerous ranges. Hypertensive crisis can cause intracranial haemorrhage. Cardiac arrhythmias can cause sudden arrest.

Seizures, when they occur, are difficult to control. Standard benzodiazepines (drugs like diazepam or lorazepam that enhance GABA-A receptor activity) can help, but NBOMe-induced seizures are frequently refractory, meaning they do not respond well to first-line treatment. Some cases have required general anaesthesia to terminate seizure activity.

Kidney failure secondary to rhabdomyolysis and dehydration completes the picture in severe cases. A person can develop multiple organ failure within hours of ingestion.

How to Tell NBOMe Apart from LSD Before You Use It

The most reliable method is reagent testing. The Ehrlich reagent is commonly used to screen for indole-containing compounds, which includes LSD, psilocybin, and DMT. LSD turns purple with Ehrlich. NBOMes do not react with Ehrlich because they are phenethylamines, not indoles.

If a tab does not turn purple with an Ehrlich test, it is not LSD. It may be NBOMe, or it may be something else entirely.

The Hofmann reagent also turns blue-green with LSD and produces a different colour with NBOMe variants.

Drug checking services where available can also use mass spectrometry or HPLC to confirm the compound. The NZ Drug Foundation and similar harm reduction organisations in various countries run these services.

One practical point: if a blotter tab tastes bitter or metallic, that is a warning sign. LSD is typically tasteless at the doses present on a single tab. NBOMes are active at microgram doses but they have a bitter, numbing quality that some users describe as unpleasant. This is not a reliable test, but it is worth knowing.

NBOMe and Mental Health Consequences

The acute psychological effects can be severe even when the physical crisis is avoided. Bad trips on NBOMes are described consistently as more intense, more physically overwhelming, and more difficult to contain than bad trips on LSD. The body load, meaning physical discomfort including muscle tension, jaw clenching, and cardiovascular awareness, is much heavier.

People who experience severe NBOMe-induced psychosis can develop persisting symptoms. Hallucinogen Persisting Perception Disorder (HPPD) is documented with classical psychedelics and there is clinical evidence that NBOMes can trigger or worsen it. HPPD involves persistent visual disturbances, trailing effects, and geometric patterns that continue for weeks or months after last use.

Pre-existing psychotic disorders, or a family history of schizophrenia or bipolar disorder, significantly increase the risk of a prolonged psychotic episode. This is not a reason to simply avoid NBOMe if someone has those conditions. It is a reason to understand that the risk of a psychiatric emergency is substantially higher.

NBOMe and Other Drugs: Dangerous Combinations

Combining NBOMe with stimulants is particularly dangerous. MDMA, amphetamines, and cocaine all raise heart rate and blood pressure independently. Combined with the cardiovascular effects of NBOMe, this pushes the system toward hypertensive crisis and arrhythmia much faster. Many of the documented NBOMe deaths involved polydrug use, and stimulant combinations were frequently present.

Mixing NBOMe with lithium, which is prescribed for bipolar disorder, is a well-recognised dangerous combination for all serotonergic psychedelics. It dramatically increases seizure risk. Anyone on lithium should never take a serotonergic drug, full stop.

Cannabis is often used alongside psychedelics to manage anxiety. With NBOMe, this approach backfires reliably. Cannabis at high doses intensifies the paranoia and psychosis components and makes the overall experience harder to manage. This is a pattern that comes up repeatedly in case reports.

NBOMe Tolerance and Dependence

NBOMe does not produce physical dependence the way opioids or alcohol do. You will not have withdrawal symptoms if you stop using it. There is no documented withdrawal syndrome.

Tolerance develops rapidly, within days of repeated use, through downregulation of 5-HT2A receptors. The receptors reduce in number and sensitivity when flooded repeatedly. Most users find that taking NBOMe on consecutive days produces diminishing effects, and the tolerance takes roughly one to two weeks to reset. Cross-tolerance with LSD and other classical psychedelics occurs through the same receptor mechanism.

That said, the absence of physical dependence does not mean NBOMes are harmless to continue using. The risk is not addiction in the traditional sense. It is a single exposure causing irreversible harm.

NBOMe Compared to Other Psychedelics

Understanding where NBOMe sits relative to other psychedelics helps clarify the specific risks. It is worth comparing it directly to LSD and 2C-B, which are the drugs it is most often confused with or sold alongside.

The key clinical difference is that NBOMe full agonism at 5-HT2A and 5-HT2B, combined with narrow dose-to-toxicity margins and inconsistent blotter manufacturing, makes it categorically more dangerous than the classical psychedelics it imitates. If you want to understand 2C-B further, our page on the 2C-B drug covers the pharmacology in detail. For the DMT comparison, the DMT drug page addresses the indole class separately.

Is NBOMe Legal?

In most countries, yes, it is now controlled. The United States scheduled 25I-NBOMe, 25C-NBOMe, and 25B-NBOMe as Schedule I substances in 2013. The United Kingdom placed NBOMes under the Psychoactive Substances Act in 2016. Australia, New Zealand, and most of Europe have controls in place.

Thailand, where Phuket Island Rehab operates, controls psychedelic substances under the Narcotics Act. NBOMes fall within the synthetic psychedelic category and possession carries serious legal penalties.

The scheduling came after a wave of deaths, primarily in young people at music festivals and private settings, between 2012 and 2016. The WHO reviewed NBOMe compounds and recommended international control. Despite legal status, the compounds remain accessible on darknet markets, which is why clinical teams continue to see exposure cases.

Psychedelic drugs like NBOMes do not typically cause the compulsive craving pattern seen with opioids or alcohol. But the DSM-5 recognises Hallucinogen Use Disorder, and the broader picture of repeated psychedelic use in contexts of risk-taking, poor mental health, or trauma deserves clinical attention. The more common concern is that someone who has had a severe NBOMe experience, including a psychotic episode, persistent perceptual disturbances, or physical harm, is not getting follow-up support. The acute event passes. The psychological aftermath often does not.

At Phuket Island Rehab, we work with people who have had traumatic drug experiences, including those involving synthetic psychedelics, who are struggling with ongoing anxiety, HPPD symptoms, or patterns of substance use that feel out of control. If that description fits you or someone close to you, a confidential assessment is the right first step.

NBOMe drugs are not a safer alternative to LSD. They are a synthetic psychedelic with a narrow margin between the dose that causes hallucinations and the dose that causes seizures, cardiac arrest, or death. They are pharmacologically distinct from classical psychedelics in two critical ways: they are full agonists at the 5-HT2A receptor rather than partial agonists, and they activate 5-HT2B receptors in cardiac tissue. These differences explain why LSD has no confirmed human fatality and NBOMe has a documented global death toll. The hazard is compounded by the fact that they are nearly always sold as something else, distributed on blotter paper indistinguishable from LSD tabs, and manufactured without quality control, meaning dose variability is extreme.

The practical implications are clear. Anyone who takes blotter paper without reagent testing is taking a risk they may not be aware of. Anyone who sees signs of NBOMe toxicity, especially seizure, extreme agitation, or hyperthermia, needs emergency services immediately, not a calm environment and reassurance. Anyone struggling with the psychological aftermath of a severe psychedelic experience, including persisting visual disturbances or intrusive memories, deserves proper clinical assessment rather than the assumption that it will simply pass. As John A. Smith of Phuket Island Rehab puts it: “I have sat with patients who had no idea what they had taken. They thought they were having an unusually rough LSD trip. By the time they got to us, some of them had been through seizures, hospitalisation, and weeks of psychotic symptoms. The compound that did that is still being sold at the same festivals, on the same blotters. The name on the label means nothing without a test.”

What is the difference between NBOMe and LSD?

NBOMe drugs are synthetic phenethylamine psychedelics that act as full agonists at the 5-HT2A serotonin receptor, while LSD is an indole alkaloid and partial agonist at the same receptor. In clinical terms, full agonism means NBOMe activates the receptor to its maximum capacity, while LSD does not. This difference in receptor pharmacology, combined with additional 5-HT2B cardiac receptor activation by NBOMe, explains why NBOMe has caused deaths and LSD has not been confirmed as a direct cause of human fatality. They are also visually identical on blotter paper, which is the source of most dangerous mix-ups.

How dangerous is an NBOMe drug overdose?

NBOMe overdose is potentially fatal and should be treated as a medical emergency. The primary causes of death include hyperthermia, seizure, cardiac arrhythmia, and multi-organ failure secondary to rhabdomyolysis. The danger is compounded by the narrow therapeutic index, meaning the dose that produces the desired effects sits close to the dose that causes toxicity. Standard overdose timelines can develop rapidly, with severe symptoms appearing within one to two hours of ingestion.

Can you test a tab to find out if it is NBOMe or LSD?

Yes. The Ehrlich reagent test is the most accessible screening tool. LSD turns the reagent purple; NBOMe does not produce a colour reaction because it is a phenethylamine, not an indole. The Hofmann reagent provides an additional confirmatory step. Neither test is a guarantee, but a negative Ehrlich result on blotter paper is a strong indication the tab does not contain LSD. Drug checking services using mass spectrometry or HPLC can provide definitive identification.

What are the signs that someone is having an NBOMe overdose rather than a bad trip?

The distinguishing features of NBOMe toxicity compared to a difficult psychedelic experience are primarily physical. Seizures, loss of consciousness, severe hypertension, heart rate above 140 beats per minute, body temperature that is dangerously elevated, and profuse sweating or conversely hot dry skin are signs of physiological crisis, not psychological distress. A standard bad trip on LSD produces extreme fear and disorientation but does not typically involve convulsions or hyperthermia. If physical symptoms dominate the picture, emergency services are needed.

Does NBOMe cause addiction or dependence?

NBOMe does not cause physical dependence, and there is no withdrawal syndrome documented when use stops. Rapid tolerance develops within days through 5-HT2A receptor downregulation, which naturally limits consecutive-day use for most people. However, the absence of addiction risk does not make NBOMe safe. The real risk is irreversible harm from a single exposure, including death, prolonged psychosis, or Hallucinogen Persisting Perception Disorder.

Why do people sometimes feel nothing from an NBOMe tab and then take more?

NBOMe is not reliably absorbed through the stomach. It requires sublingual or buccal absorption, meaning it needs to be held in contact with mucous membranes in the mouth. If a tab is swallowed rather than held under the tongue, absorption is minimal and delayed. The delayed onset also means effects may not appear for 30 to 45 minutes even with correct administration. Both factors lead users to redose before the first dose has taken effect, which is a major driver of overdose events.

What should I do if someone has taken NBOMe and is having a bad reaction?

Call emergency services immediately if there are any physical signs such as seizure, loss of consciousness, chest pain, severe confusion, or dangerously high body temperature. Do not wait to see if the symptoms improve. Move the person to a calm environment away from stimulation if they are conscious and responsive, but do not leave them alone. Be honest with paramedics about what was taken, including your best guess if you are not certain. In most jurisdictions, Good Samaritan laws protect people who call for help during a drug emergency from possession charges.